These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 19335509)

  • 1. MTA pulpotomy of human permanent molars with irreversible pulpitis.
    Eghbal MJ; Asgary S; Baglue RA; Parirokh M; Ghoddusi J
    Aust Endod J; 2009 Apr; 35(1):4-8. PubMed ID: 19335509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological, ultrastructural and quantitative investigations on the response of healthy human pulps to experimental capping with mineral trioxide aggregate: a randomized controlled trial.
    Nair PN; Duncan HF; Pitt Ford TR; Luder HU
    Int Endod J; 2008 Feb; 41(2):128-50. PubMed ID: 17956562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histology of Irreversible pulpitis premolars treated with mineral trioxide aggregate pulpotomy.
    Chueh LH; Chiang CP
    Oper Dent; 2010; 35(3):370-4. PubMed ID: 20533639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.
    Alqaderi HE; Al-Mutawa SA; Qudeimat MA
    J Dent; 2014 Nov; 42(11):1390-5. PubMed ID: 24973732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial.
    Asgary S; Eghbal MJ
    Acta Odontol Scand; 2013 Jan; 71(1):130-6. PubMed ID: 22339289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth.
    Aeinehchi M; Dadvand S; Fayazi S; Bayat-Movahed S
    Int Endod J; 2007 Apr; 40(4):261-7. PubMed ID: 17309744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    Pediatr Dent; 2008; 30(3):220-4. PubMed ID: 18615987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vital pulp therapy with new materials: new directions and treatment perspectives--permanent teeth.
    Witherspoon DE
    J Endod; 2008 Jul; 34(7 Suppl):S25-8. PubMed ID: 18565368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dentin bridge formation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth.
    Maroto M; Barbería E; Planells P; García Godoy F
    Am J Dent; 2005 Jun; 18(3):151-4. PubMed ID: 16158803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of mineral trioxide aggregate, calcium hydroxide and formocresol for pulpotomies in primary teeth.
    Moretti AB; Sakai VT; Oliveira TM; Fornetti AP; Santos CF; Machado MA; Abdo RC
    Int Endod J; 2008 Jul; 41(7):547-55. PubMed ID: 18479381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Outcomes of Mineral Trioxide Aggregate Pulpotomy in Vital Permanent Teeth with Carious Pulp Exposure: The Retrospective Study.
    Linsuwanont P; Wimonsutthikul K; Pothimoke U; Santiwong B
    J Endod; 2017 Feb; 43(2):225-230. PubMed ID: 28041685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation platelet concentrate (PRF) as a pulpotomy medicament in a permanent molar with pulpitis: a case report.
    Hiremath H; Saikalyan S; Kulkarni SS; Hiremath V
    Int Endod J; 2012 Jan; 45(1):105-12. PubMed ID: 22077790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological evaluation of mineral trioxide aggregate and calcium hydroxide in direct pulp capping of human immature permanent teeth.
    Sawicki L; Pameijer CH; Emerich K; Adamowicz-Klepalska B
    Am J Dent; 2008 Aug; 21(4):262-6. PubMed ID: 18795524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol.
    Holan G; Eidelman E; Fuks AB
    Pediatr Dent; 2005; 27(2):129-36. PubMed ID: 15926290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineral trioxide aggregate produces superior outcomes in vital primary molar pulpotomy.
    Doyle TL; Casas MJ; Kenny DJ; Judd PL
    Pediatr Dent; 2010; 32(1):41-7. PubMed ID: 20298652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial Pulpotomy in Mature Permanent Teeth with Clinical Signs Indicative of Irreversible Pulpitis: A Randomized Clinical Trial.
    Taha NA; Khazali MA
    J Endod; 2017 Sep; 43(9):1417-1421. PubMed ID: 28673494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineral trioxide aggregate pulpotomy for permanent molars with clinical signs indicative of irreversible pulpitis: a preliminary study.
    Qudeimat MA; Alyahya A; Hasan AA
    Int Endod J; 2017 Feb; 50(2):126-134. PubMed ID: 26841969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal outcomes of pulpotomy in young patients: Long-term prospects for permanent molars with signs and symptoms indicative of irreversible pulpitis.
    Alyahya A; Qudeimat MA
    J Dent; 2024 Aug; 147():105132. PubMed ID: 38901324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two mineral trioxide aggregate compounds as pulp-capping agents in human teeth.
    Accorinte ML; Loguercio AD; Reis A; Bauer JR; Grande RH; Murata SS; Souza V; Holland R
    Int Endod J; 2009 Feb; 42(2):122-8. PubMed ID: 19134040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.